1995;92:1731 6. 603. Elbarouni B, Ismaeil N, Yan RT, et al. Temporal changes in the manage- ment and outcome of Canadian diabetic patients hospitalized for non-ST- elevation acute coronary syndromes. Am Heart J. 2011;162:347 55. 604. Kristensen TS, Kofoed KF, Kuhl JT, et al. Prognostic implications of nonobstructive coronary plaques in patients with non-ST-segment eleva- tion myocardial infarction: a multidetector computed tomography study. J Am Coll Cardiol. 2011;58:502 9. 605. Sanchez PL, Morinigo JL, Pabon P, et al. Prognostic relations between inflammatory markers and mortality in diabetic patients with non-ST elevation acute coronary syndrome. Heart. 2004;90:264 9. 606. Ting HH, Chen AY, Roe MT, et al. Delay from symptom onset to hospi- tal presentation for patients with non-ST-segment elevation myocardial infarction. Arch Intern Med. 2010;170:1834 41. 607. Hasin T, Hochadel M, Gitt AK, et al. Comparison of treatment and out- come of acute coronary syndrome in patients with versus patients with- out diabetes mellitus. Am J Cardiol. 2009;103:772 8. 608. Finfer S, Chittock DR, Su SY, et al. Intensive versus conventional glu- cose control in critically ill patients. N Engl J Med. 2009;360:1283 97. 609. Rao SV, Ou FS, Wang TY, et al. Trends in the prevalence and outcomes of radial and femoral approaches to percutaneous coronary intervention: a report from the National Cardiovascular Data Registry. JACC Cardiovasc Interv. 2008;1:379 86. 610. Agostoni P, Biondi-Zoccai GG, de Benedictis ML, et al. Radial versus femoral approach for percutaneous coronary diagnostic and interven- tional procedures: systematic overview and meta-analysis of randomized trials. J Am Coll Cardiol. 2004;44:349 56. 611. ChaseAJ, Fretz EB,WarburtonWP, et al.Association of the arterial access site at angioplasty with transfusion and mortality: the M.O.R.T.A.L study (Mortality benefit Of Reduced Transfusion after percutaneous coronary intervention via the Arm or Leg). Heart. 2008;94:1019 25. 612. 